Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 963

1.

Changes in the gene mutation profiles of circulating tumor DNA detected using CAPP-Seq in neoadjuvant chemotherapy-treated advanced ovarian cancer.

Noguchi T, Sakai K, Iwahashi N, Matsuda K, Matsukawa H, Yahata T, Toujima S, Nishio K, Ino K.

Oncol Lett. 2020 Apr;19(4):2713-2720. doi: 10.3892/ol.2020.11356. Epub 2020 Jan 28.

PMID:
32218822
2.

Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS/p38 and JNK signalling during the development of polycystic ovary syndrome.

Kobayashi M, Yoshino O, Nakashima A, Ito M, Nishio K, Ono Y, Kusabiraki T, Kunitomi C, Takahashi N, Harada M, Hattori K, Orisaka M, Osuga Y, Saito S.

Mol Cell Endocrinol. 2020 Mar 18:110792. doi: 10.1016/j.mce.2020.110792. [Epub ahead of print]

PMID:
32199904
3.

[Undifferentiated Carcinoma of the Gallbladder with Rapid Postoperative Progression-A Case Report].

Tashima T, Murata A, Shimizu S, Kushiyama S, Hamano G, Kinoshita M, Nishio K, Sakurai K, Nishii T, Kodai S, Tachimori A, Tamamori Y, Kubo N, Ikeda K, Kanazawa A.

Gan To Kagaku Ryoho. 2019 Dec;46(13):2524-2526. Japanese.

PMID:
32156986
4.

Structural and biochemical characterization of mitochondrial citrate synthase 4 from Arabidopsis thaliana.

Nishio K, Mizushima T.

Acta Crystallogr F Struct Biol Commun. 2020 Mar 1;76(Pt 3):109-115. doi: 10.1107/S2053230X20001521. Epub 2020 Mar 1.

PMID:
32133996
5.

Study of Quasielastic Barrier Distributions as a Step towards the Synthesis of Superheavy Elements with Hot Fusion Reactions.

Tanaka T, Morita K, Morimoto K, Kaji D, Haba H, Boll RA, Brewer NT, Van Cleve S, Dean DJ, Ishizawa S, Ito Y, Komori Y, Nishio K, Niwase T, Rasco BC, Roberto JB, Rykaczewski KP, Sakai H, Stracener DW, Hagino K.

Phys Rev Lett. 2020 Feb 7;124(5):052502. doi: 10.1103/PhysRevLett.124.052502.

PMID:
32083897
6.

Importance Of Laboratory Detection Of Macro-Aspartate Aminotransferase.

Ono S, Kurata C, Nishimura N, Kawashima H, Yoneima R, Tai Y, Tatsumi E, Miyamoto M, Yada N, Yoshimoto K, Nishio K.

Int J Gen Med. 2019 Nov 26;12:433-436. doi: 10.2147/IJGM.S224281. eCollection 2019.

7.

Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

Takahama T, Azuma K, Shimokawa M, Takeda M, Ishii H, Kato T, Saito H, Daga H, Tsuboguchi Y, Okamoto I, Otsubo K, Akamatsu H, Teraoka S, Takahashi T, Ono A, Ohira T, Yokoyama T, Sakai K, Yamamoto N, Nishio K, Nakagawa K.

Cancer. 2020 Feb 5. doi: 10.1002/cncr.32749. [Epub ahead of print]

PMID:
32022929
8.

Electronic structure of AlFeN films exhibiting crystallographic orientation change from c- to a-axis with Fe concentrations and annealing effect.

Tatemizo N, Imada S, Okahara K, Nishikawa H, Tsuruta K, Ina T, Miura Y, Nishio K, Isshiki T.

Sci Rep. 2020 Feb 4;10(1):1819. doi: 10.1038/s41598-020-58835-5.

9.

Determination of Somatic Mutations and Tumor Mutation Burden in Plasma by CAPP-Seq during Afatinib Treatment in NSCLC Patients Resistance to Osimertinib.

Ishii H, Azuma K, Sakai K, Naito Y, Matsuo N, Tokito T, Yamada K, Hoshino T, Nishio K.

Sci Rep. 2020 Jan 20;10(1):691. doi: 10.1038/s41598-020-57624-4.

10.

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors.

Yonesaka K, Iwama E, Hayashi H, Suzuki S, Kato R, Watanabe S, Takahama T, Tanizaki J, Tanaka K, Takeda M, Sakai K, Azuma K, Chiba Y, Atagi S, Nishio K, Okamoto I, Nakagawa K.

Sci Rep. 2019 Dec 20;9(1):19501. doi: 10.1038/s41598-019-55939-5.

11.

Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course.

Takaya H, Nakai H, Sakai K, Nishio K, Murakami K, Mandai M, Matsumura N.

Gynecol Oncol. 2020 Feb;156(2):415-422. doi: 10.1016/j.ygyno.2019.11.013. Epub 2019 Nov 27.

PMID:
31785864
12.

A Preclinical Evaluation towards the Clinical Application of Oxygen Consumption Measurement by CERMs by a Mouse Chimera Model.

Kuno T, Tachibana M, Fujimine-Sato A, Fue M, Higashi K, Takahashi A, Kurosawa H, Nishio K, Shiga N, Watanabe Z, Yaegashi N.

Int J Mol Sci. 2019 Nov 12;20(22). pii: E5650. doi: 10.3390/ijms20225650.

13.

Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIs.

Takeda M, Sakai K, Hayashi H, Tanaka K, Haratani K, Takahama T, Kato R, Yonesaka K, Nishio K, Nakagawa K.

Lung Cancer. 2020 Jan;139:28-34. doi: 10.1016/j.lungcan.2019.10.028. Epub 2019 Nov 3.

PMID:
31710890
14.

U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.

Haratani K, Yonesaka K, Takamura S, Maenishi O, Kato R, Takegawa N, Kawakami H, Tanaka K, Hayashi H, Takeda M, Maeda N, Kagari T, Hirotani K, Tsurutani J, Nishio K, Doi K, Miyazawa M, Nakagawa K.

J Clin Invest. 2020 Jan 2;130(1):374-388. doi: 10.1172/JCI126598.

15.

Low-Energy-Consumption Three-Valued Memory Device Inspired by Solid-State Batteries.

Watanabe Y, Kobayashi S, Sugiyama I, Nishio K, Liu W, Watanabe S, Shimizu R, Hitosugi T.

ACS Appl Mater Interfaces. 2019 Dec 4;11(48):45150-45154. doi: 10.1021/acsami.9b15366. Epub 2019 Nov 15.

PMID:
31651152
16.

Relationship between the nutritional state of elderly people in need of support or nursing care and jaw-opening force and tongue pressure.

Hoyano K, Tsujihashi E, Nishio K, Tsuji T.

J Phys Ther Sci. 2019 Oct;31(10):747-750. doi: 10.1589/jpts.31.747. Epub 2019 Oct 19.

17.

Association between timing of hot water bathing before bedtime and night-/sleep-time blood pressure and dipping in the elderly: a longitudinal analysis for repeated measurements in home settings.

Tai Y, Saeki K, Yamagami Y, Yoshimoto K, Kurumatani N, Nishio K, Obayashi K.

Chronobiol Int. 2019 Dec;36(12):1714-1722. doi: 10.1080/07420528.2019.1675685. Epub 2019 Oct 15.

PMID:
31610699
18.

Functional regulation of von Willebrand factor ameliorates acute ischemia-reperfusion kidney injury in mice.

Ono S, Matsui H, Noda M, Kasuda S, Yada N, Yoshimoto K, Akiyama M, Miyata T, Sugimoto M, Nishio K.

Sci Rep. 2019 Oct 8;9(1):14453. doi: 10.1038/s41598-019-51013-2.

19.

Vitrification and nanocrystallization of pure liquid Ni studied using molecular-dynamics simulation.

Louzguine-Luzgin DV, Miyama M, Nishio K, Tsarkov AA, Greer AL.

J Chem Phys. 2019 Sep 28;151(12):124502. doi: 10.1063/1.5119307.

PMID:
31575179
20.

Aberrant HER3 ligand heregulin-expressing head and neck squamous cell carcinoma is resistant to anti-EGFR antibody cetuximab, but not second-generation EGFR-TKI.

Yonesaka K, Tanaka K, Kitano M, Kawakami H, Hayashi H, Takeda M, Sakai K, Nishio K, Doi K, Nakagawa K.

Oncogenesis. 2019 Sep 30;8(10):54. doi: 10.1038/s41389-019-0164-9.

21.

[Current Status and Future Direction of Cancer Genomic Medicine].

Nishio K, Sakai K.

Gan To Kagaku Ryoho. 2019 Sep;46(9):1357-1360. Japanese.

PMID:
31530770
22.

Clinical and immune profiling for cancer of unknown primary site.

Haratani K, Hayashi H, Takahama T, Nakamura Y, Tomida S, Yoshida T, Chiba Y, Sawada T, Sakai K, Fujita Y, Togashi Y, Tanizaki J, Kawakami H, Ito A, Nishio K, Nakagawa K.

J Immunother Cancer. 2019 Sep 13;7(1):251. doi: 10.1186/s40425-019-0720-z.

23.

Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.

Iwama E, Sakai K, Hidaka N, Inoue K, Fujii A, Nakagaki N, Ota K, Toyozawa R, Azuma K, Nakatomi K, Harada T, Hisasue J, Sakata S, Shimose T, Kishimoto J, Nakanishi Y, Nishio K, Okamoto I.

Cancer. 2020 Jan 1;126(1):219-227. doi: 10.1002/cncr.32481. Epub 2019 Sep 10.

PMID:
31503343
24.

Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy.

De Velasco MA, Kura Y, Sakai K, Hatanaka Y, Davies BR, Campbell H, Klein S, Kim Y, MacLeod AR, Sugimoto K, Yoshikawa K, Nishio K, Uemura H.

JCI Insight. 2019 Sep 5;4(17). pii: 122688. doi: 10.1172/jci.insight.122688.

25.

Difficulty classifications of laparoscopic repeated liver resection in patients with recurrent hepatocellular carcinoma.

Kinoshita M, Kanazawa A, Kodai S, Shimizu S, Murata A, Nishio K, Hamano G, Shinkawa H, Tanaka S, Takemura S, Tsukamoto T, Kubo S.

Asian J Endosc Surg. 2019 Aug 13. doi: 10.1111/ases.12746. [Epub ahead of print]

PMID:
31408275
26.

A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.

Sakai K, Takeda M, Shimizu S, Takahama T, Yoshida T, Watanabe S, Iwasa T, Yonesaka K, Suzuki S, Hayashi H, Kawakami H, Nonagase Y, Tanaka K, Tsurutani J, Saigoh K, Ito A, Mitsudomi T, Nakagawa K, Nishio K.

Sci Rep. 2019 Aug 5;9(1):11340. doi: 10.1038/s41598-019-47673-9.

27.

Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.

Kitazono S, Sakai K, Yanagitani N, Ariyasu R, Yoshizawa T, Dotsu Y, Koyama J, Saiki M, Sonoda T, Nishikawa S, Uchibori K, Horiike A, Nishio K, Nishio M.

Cancer Sci. 2019 Oct;110(10):3350-3357. doi: 10.1111/cas.14153. Epub 2019 Aug 19.

28.

Successful long-term treatment of non-small cell lung cancer positive for RET rearrangement with pemetrexed.

Takeda M, Sakai K, Nishio K, Nakagawa K.

Onco Targets Ther. 2019 Jul 8;12:5355-5358. doi: 10.2147/OTT.S211582. eCollection 2019.

29.

Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing.

Iwahashi N, Sakai K, Noguchi T, Yahata T, Matsukawa H, Toujima S, Nishio K, Ino K.

Sci Rep. 2019 Jul 18;9(1):10426. doi: 10.1038/s41598-019-47030-w.

30.

A Case of Metastatic Malignant Breast Adenomyoepithelioma With a Codon-61 Mutation of HRAS.

Watanabe S, Otani T, Iwasa T, Takahama T, Takeda M, Sakai K, Nishio K, Ito A, Nakagawa K.

Clin Breast Cancer. 2019 Oct;19(5):e589-e592. doi: 10.1016/j.clbc.2019.05.001. Epub 2019 Jun 20. No abstract available.

PMID:
31301988
31.

Reply to A.-M. Conway et al.

Hayashi H, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Aug 10;37(23):2090. doi: 10.1200/JCO.19.00767. Epub 2019 Jun 18. No abstract available.

PMID:
31211602
32.

New Era for Next-Generation Sequencing in Japan.

Takeda M, Sakai K, Takahama T, Fukuoka K, Nakagawa K, Nishio K.

Cancers (Basel). 2019 May 28;11(6). pii: E742. doi: 10.3390/cancers11060742. Review.

33.

Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.

Kunimasa K, Nakamura H, Sakai K, Tamiya M, Kimura M, Inoue T, Nishino K, Kuhara H, Nakatsuka SI, Nishio K, Imamura F, Kumagai T.

Lung Cancer. 2019 Jun;132:59-64. doi: 10.1016/j.lungcan.2019.03.029. Epub 2019 Apr 8.

PMID:
31097095
34.

Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA.

Otsubo K, Sakai K, Takeshita M, Harada D, Azuma K, Ota K, Akamatsu H, Goto K, Horiike A, Kurata T, Nakagaki N, Nosaki K, Iwama E, Nakanishi Y, Nishio K, Okamoto I.

Oncologist. 2019 Aug;24(8):1022-1026. doi: 10.1634/theoncologist.2019-0101. Epub 2019 Apr 25.

35.

Spatiotemporal observations of light propagation in multiple polarization states.

Inoue T, Matsunaka A, Funahashi A, Okuda T, Nishio K, Awatsuji Y.

Opt Lett. 2019 Apr 15;44(8):2069-2072. doi: 10.1364/OL.44.002069.

PMID:
30985813
36.

Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.

Sakai K, Ohira T, Matsubayashi J, Yoneshige A, Ito A, Mitsudomi T, Nagao T, Iwamatsu E, Katayama J, Ikeda N, Nishio K.

Cancer Sci. 2019 Jun;110(6):2044-2049. doi: 10.1111/cas.14016. Epub 2019 May 3.

37.

Entropy-driven docosahedral short-range order in simple liquids and glasses.

Nishio K, Lu AKA, Miyazaki T.

Phys Rev E. 2019 Feb;99(2-1):022121. doi: 10.1103/PhysRevE.99.022121.

PMID:
30934319
38.

Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.

Kinoshita M, Kanazawa A, Takemura S, Tanaka S, Kodai S, Shinkawa H, Shimizu S, Murata A, Nishio K, Hamano G, Ito T, Tsukamoto T, Kubo S.

Asian J Endosc Surg. 2020 Jan;13(1):46-58. doi: 10.1111/ases.12703. Epub 2019 Mar 28.

PMID:
30924307
39.

Substitutional and interstitial impurity p-type doping of thermoelectric Mg2Si: a theoretical study.

Hirayama N, Iida T, Sakamoto M, Nishio K, Hamada N.

Sci Technol Adv Mater. 2019 Mar 14;20(1):160-172. doi: 10.1080/14686996.2019.1580537. eCollection 2019.

40.

Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN with RS-T) complicated by hyperleukocytosis and gene analysis in relation to leukocytosis.

Aoyama Y, Sakai K, Kodaka T, Tsunemine H, Nishio K, Itoh T, Inoue D, Takahashi T.

J Clin Exp Hematop. 2019 Mar 27;59(1):29-33. doi: 10.3960/jslrt.18037. Epub 2019 Feb 7.

41.

RASGRP2 Suppresses Apoptosis via Inhibition of ROS Production in Vascular Endothelial Cells.

Sato T, Takino JI, Nagamine K, Nishio K, Hori T.

ScientificWorldJournal. 2019 Jan 1;2019:4639165. doi: 10.1155/2019/4639165. eCollection 2019.

42.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
43.

Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion.

Sakai H, Takeda M, Sakai K, Nakamura Y, Ito A, Hayashi H, Tanaka K, Nishio K, Nakagawa K.

Lung Cancer. 2019 Jan;127:59-65. doi: 10.1016/j.lungcan.2018.11.025. Epub 2018 Nov 23.

PMID:
30642552
44.

HOXA10 expression profiling in prostate cancer.

Hatanaka Y, de Velasco MA, Oki T, Shimizu N, Nozawa M, Yoshimura K, Yoshikawa K, Nishio K, Uemura H.

Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6.

PMID:
30614022
45.

Evolution of Reactions of a Fluoride Shuttle Battery at the Surfaces of BiF3 Microclusters Studied by In Situ Raman Microscopy.

Yamanaka T, Okazaki KI, Abe T, Nishio K, Ogumi Z.

ChemSusChem. 2019 Jan 24;12(2):527-534. doi: 10.1002/cssc.201802209. Epub 2019 Jan 2.

PMID:
30450797
46.

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Fujita Y, Taguri M, Yamazaki K, Tsurutani J, Sakai K, Tsushima T, Nagase M, Tamagawa H, Ueda S, Tamura T, Tsuji Y, Murata K, Taira K, Denda T, Moriwaki T, Funai S, Nakajima TE, Muro K, Tsuji A, Yoshida M, Suyama K, Kurimoto T, Sugimoto N, Baba E, Seki N, Sato M, Shimura T, Boku N, Hyodo I, Yamanaka T, Nishio K.

Oncologist. 2019 Mar;24(3):327-337. doi: 10.1634/theoncologist.2018-0119. Epub 2018 Nov 13.

47.

A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report.

Iwahashi N, Sakai K, Noguchi T, Yahata T, Toujima S, Nishio K, Ino K.

Oncol Lett. 2018 Nov;16(5):6431-6436. doi: 10.3892/ol.2018.9467. Epub 2018 Sep 20.

48.

Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.

Watanabe S, Hayashi H, Haratani K, Shimizu S, Tanizaki J, Sakai K, Kawakami H, Yonesaka K, Tsurutani J, Togashi Y, Nishio K, Ito A, Nakagawa K.

Cancer Sci. 2019 Jan;110(1):52-60. doi: 10.1111/cas.13860. Epub 2018 Nov 27.

49.

Extending recordable time of light-in-flight recording by holography with double reference light pulses.

Sawashima Y, Yamanaka D, Takamoto I, Matsunaka A, Awatsuji Y, Nishio K.

Opt Lett. 2018 Oct 15;43(20):5146-5149. doi: 10.1364/OL.43.005146.

PMID:
30320841
50.

Serpina3n, Dominantly Expressed in Female Osteoblasts, Suppresses the Phenotypes of Differentiated Osteoblasts in Mice.

Ishida M, Kawao N, Okada K, Tatsumi K, Sakai K, Nishio K, Kaji H.

Endocrinology. 2018 Nov 1;159(11):3775-3790. doi: 10.1210/en.2018-00639.

PMID:
30304388

Supplemental Content

Loading ...
Support Center